Swiss lawmakers reject medicine-supply initiative in favour of government plan

The National Council rejected the medicines security initiative on September 24, 2026, and endorsed the Federal Council’s narrower counter-proposal. The vote keeps Switzerland’s response to recurring medicine shortages inside the government’s proposed framework, while leaving the final parliamentary position unfinished because the Council of States has not yet debated either measure.

The popular initiative, titled ‘Yes to the security of medical supplies’, called for stronger Swiss research, development, production and stockpiling across the entire medicines value chain. Representatives of the initiative said at its submission that hundreds of medicines were in short supply in Switzerland. The proposal was submitted in 2024 by 20 organisations and companies from the healthcare sector.

National Council members accepted that the supply problem was real. They judged the initiative too broadly worded and considered its demands too far-reaching. The chamber therefore chose the government’s direct counter-proposal, which focuses on powers for the Confederation to monitor availability and intervene when disruptions emerge.

The decision now sends the issue into the next stage of the parliamentary process. The upper chamber must still examine the initiative and the alternative backed by the National Council.

The counter-proposal would give the Confederation a central role in detecting shortages before they become acute. Under the government’s plan, federal authorities would monitor the medicine supply situation centrally and proactively. They would also gain the ability to take measures designed to prevent or remedy interruptions.

That would create a national oversight structure for a problem that can affect hospitals, pharmacies and patients across cantonal borders. The proposal does not rely on a single remedy. It combines monitoring with economic incentives, procurement and the option to manufacture medical supplies in Switzerland or arrange for domestic production.

The plan also calls for stronger international cooperation. Switzerland depends heavily on cross-border supply chains for medicines and active pharmaceutical ingredients, so the government’s approach recognises that domestic capacity alone cannot guarantee uninterrupted access. Officials would have a broader set of tools to respond when suppliers withdraw products, deliveries falter or stocks fall.

The National Council’s support reflects its preference for a targeted legal framework rather than the initiative’s wider demands covering research, development, production and storage. The precise design, financing and implementation of the counter-proposal will depend on the remaining parliamentary debate.

Switzerland’s medicine shortage debate grew from repeated disruptions that exposed vulnerabilities in the supply chain. Initiative supporters said at its launch that hundreds of medicines were unavailable or difficult to obtain. Their response focused on the full chain, from Swiss research and development to production and storage.

That ambition attracted support from healthcare organisations and companies, yet it also shaped the National Council’s objection. Lawmakers considered the initiative too broad and too prescriptive. The counter-proposal keeps the state’s response more focused on supply security, giving federal authorities mechanisms to identify risks and act when shortages threaten patients.

The debate also carries a geopolitical dimension. Swissinfo has reported that experts see possible effects on medicine availability from international crises, even when immediate shortages are not expected. Global transport routes, manufacturing concentration and reliance on foreign suppliers can all influence what reaches Swiss pharmacies and hospitals.

The government’s proposed mix of procurement, incentives and domestic manufacturing could give Switzerland more resilience in selected areas. It would not eliminate the country’s dependence on international trade. Stronger cooperation with other countries remains part of the plan, alongside efforts to reinforce domestic capacity where it matters most.